Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
Tängdén T, Ramos Martín V, Felton TW, Nielsen EI, Marchand S, Brüggemann RJ, Bulitta JB, Bassetti M, Theuretzbacher U, Tsuji BT, Wareham DW, Friberg LE, De Waele JJ, Tam VH, Roberts JA; Infection Section for the European Society of Intensive Care Medicine, the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases, the International Society of Anti-Infective Pharmacology and the Critically Ill Patients Study Group of European Society of Clinical Microbiology and Infectious Diseases. Tängdén T, et al. Among authors: tsuji bt. Intensive Care Med. 2017 Jul;43(7):1021-1032. doi: 10.1007/s00134-017-4780-6. Epub 2017 Apr 13. Intensive Care Med. 2017. PMID: 28409203 Review.
Optimizing use of quinolones in the critically ill.
Yang JC, Tsuji BT, Forrest A. Yang JC, et al. Among authors: tsuji bt. Semin Respir Crit Care Med. 2007 Dec;28(6):586-95. doi: 10.1055/s-2007-996405. Semin Respir Crit Care Med. 2007. PMID: 18095222 Review.
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia.
Harigaya Y, Bulitta JB, Forrest A, Sakoulas G, Lesse AJ, Mylotte JM, Tsuji BT. Harigaya Y, et al. Among authors: tsuji bt. Antimicrob Agents Chemother. 2009 Sep;53(9):3894-901. doi: 10.1128/AAC.01585-08. Epub 2009 Jul 13. Antimicrob Agents Chemother. 2009. PMID: 19596879 Free PMC article.
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model.
Bulitta JB, Yang JC, Yohonn L, Ly NS, Brown SV, D'Hondt RE, Jusko WJ, Forrest A, Tsuji BT. Bulitta JB, et al. Among authors: tsuji bt. Antimicrob Agents Chemother. 2010 May;54(5):2051-62. doi: 10.1128/AAC.00881-09. Epub 2010 Mar 8. Antimicrob Agents Chemother. 2010. PMID: 20211900 Free PMC article.
Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection.
Okusanya OO, Tsuji BT, Bülitta JB, Forrest A, Bulik CC, Bhavnani SM, Fernandes P, Ambrose PG. Okusanya OO, et al. Among authors: tsuji bt. Diagn Microbiol Infect Dis. 2011 May;70(1):101-11. doi: 10.1016/j.diagmicrobio.2011.03.001. Diagn Microbiol Infect Dis. 2011. PMID: 21513848
108 results